Literature DB >> 21451448

Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.

.   

Abstract

In 2008, the World Health Organization (WHO) African Region (AFR) measles technical advisory group (TAG) recommended establishing a measles preelimination goal, to be achieved by the end of 2012. The goal sets the following targets for the 46 AFR countries: ≥98% reduction in estimated regional measles mortality compared with 2000; measles incidence of <5 cases per 1 million population per year nationally; >90% national measles-containing vaccine (MCV) first dose (MCV1) coverage and >80% MCV1 coverage in all districts; and ≥95% MCV coverage by supplementary immunization activities (SIAs) in all districts. The goal also sets surveillance performance targets of ≥2 cases of nonmeasles febrile rash illness per 100,000 population, ≥1 suspected measles cases investigated with blood specimens in ≥80% of districts, and routine reporting from all districts. In addition, introduction of a routine second MCV dose (MCV2) was recommended for countries meeting specific criteria for MCV1 coverage and measles surveillance. This report updates progress toward the preelimination goal during 2009--2010 and summarizes measles outbreaks occurring in AFR countries since 2008. Of the 46 AFR countries, 12 (26%) reported measles incidence of <5 cases per 1 million population during 2010, compared with 28 (61%) in 2008. Furthermore, 28 (61%) countries reported a laboratory-confirmed measles outbreak during 2009--2010. The recent measles outbreaks highlight the need for renewed dedication by donors and governments to ensure that national multiyear vaccination plans, national budgetary line items, and financial commitments exist for routine immunization services and measles control activities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451448

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

1.  Molecular detection of measles virus from children during a sporadic outbreak in two semi-urban areas in Nigeria.

Authors:  B A Olusola; J A Adeniji
Journal:  Afr J Infect Dis       Date:  2014

2.  Contact tracing of in-flight measles exposures: lessons from an outbreak investigation and case series, Australia, 2010.

Authors:  Frank Beard; Lucinda Franklin; Steven Donohue; Rodney Moran; Stephen Lambert; Marion Maloney; Jan Humphreys; Jessica Rotty; Nicolee Martin; Michael Lyon; Thomas Tran; Christine Selvey
Journal:  Western Pac Surveill Response J       Date:  2011-08-25

3.  Vaccines: The case of measles.

Authors: 
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

4.  Risk Factors for Measles in HIV-infected Children and Adolescents in Botswana.

Authors:  Kathleen E Wirth; Elizabeth R Wolf; David M Goldfarb; Ari Ho-Foster; Michael Tolle; Christina Jacovides; Brianna Kirk; Mamiki Chise; Andrew P Steenhoff
Journal:  Pediatr Infect Dis J       Date:  2015-10       Impact factor: 2.129

5.  Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.

Authors:  Kaitlin Rainwater-Lovett; Hope C Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn Bolton-Moore; William J Moss
Journal:  J Infect Dis       Date:  2013-08-02       Impact factor: 5.226

6.  Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.

Authors:  Heather Melissa Scobie; Benoît Kebela Ilunga; Audry Mulumba; Calixte Shidi; Tiekoura Coulibaly; Ricardo Obama; Jean-Jacques Muyembe Tamfum; Elisabeth Pukuta Simbu; Sheilagh Brigitte Smit; Balcha Masresha; Robert Tyrrell Perry; Mary Margaret Alleman; Katrina Kretsinger; James Goodson
Journal:  Pan Afr Med J       Date:  2015-05-15

7.  Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.

Authors:  Masahiko Hachiya; Shinsuke Miyano; Yoshio Mori; Emilia Vynnycky; Phath Keungsaneth; Phengta Vongphrachanh; Anonh Xeuatvongsa; Thongchanh Sisouk; Vilasak Som-Oulay; Bouaphan Khamphaphongphane; Bounthanom Sengkeopaseuth; Chansay Pathammavong; Kongxay Phounphenghak; Tomomi Kitamura; Makoto Takeda; Katsuhiro Komase
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Global control and regional elimination of measles, 2000-2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-18       Impact factor: 17.586

9.  Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool.

Authors:  Laurence Cibrelus; Clément Lingani; Katya Fernandez; Mamoudou H Djingarey; William A Perea; Stéphane Hugonnet
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

10.  Progress toward measles preelimination--African Region, 2011-2012.

Authors:  Balcha G Masresha; Reinhard Kaiser; Messeret Eshetu; Reggis Katsande; Richard Luce; Amadou Fall; Annick R G A Dosseh; Boubker Naouri; Charles R Byabamazima; Robert Perry; Alya J Dabbagh; Peter Strebel; Katrina Kretsinger; James L Goodson; Deo Nshimirimana
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-04-04       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.